Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/35334| Title: | Optimizing How We Measure Quality of Life in Drug Hypersensitivity. | Austin Authors: | Copaescu, Ana ;Trubiano, Jason | Affiliation: | Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia; Department of Medicine, Division of Allergy and Clinical Immunology, McGill University Health Centre (MUHC), McGill University, Montreal, Quebec, Canada; The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia. Centre for Antibiotic Allergy and Research Infectious Diseases |
Issue Date: | Jun-2024 | Publication information: | The journal of allergy and clinical immunology. In practice 2024-06; 12(6) | URI: | https://ahro.austin.org.au/austinjspui/handle/1/35334 | DOI: | 10.1016/j.jaip.2024.03.045 | ORCID: | Journal: | The journal of allergy and clinical immunology. In practice | Start page: | 1592 | End page: | 1593 | PubMed URL: | 38851253 | ISSN: | 2213-2201 | Type: | Journal Article | Subjects: | Drug Hypersensitivity/diagnosis |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.